CoChat

Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice

Open access
da Silva, Rafaela F., Fraga-Silva, Rodrigo A., Steffens, Sabine, Fabre, Mathias, Bauer, Inga, Caffa, Irene, Magnone, Mirko, Sociali, Giovanna, Quercioli, Alessandra, Pelli, Graziano, Lenglet, Sébastien, Galan, Katia, Burger, Fabienne, Calvo, Sara Vázquez, Bertolotto, Maria, Bruzzone, Santina, Ballestrero, Alberto, Patrone, Franco, Dallegri, Franco, Santos, Robson A. S., Stergiopulos, Nikolaos, Mach, François, Vuilleumier, Nicolas, Montecucco, Fabrizio, Nencioni, Alessio · 2014 · Thrombosis and Haemostasis
Cited by 51

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Pharmacological treatments targeting CXC chemokines and the associated neutrophil activation and recruitment into atherosclerotic plaques hold promise for treating cardiovascular disorders. Therefore, we investigated whether FK866, a nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with anti-inflammatory properties that we recently found to reduce neutrophil recruitment into the ischaemic myocardium, would exert beneficial effects in a mouse atherosclerosis model. Atherosclerotic plaque formation was induced by carotid cast implantation in ApoE-/- mice that were fed with a Western-type diet. FK866 or vehicle were administrated intraperitoneally from week 8 until week 11 of the diet. Treatment with FK866 reduced neutrophil infiltration and MMP-9 content and increased collagen levels in atherosclerotic plaques compared to vehicle. No effect on other histological parameters, including intraplaque lipids or macrophages, was observed. These findings were associated with a reduction in both systemic and intraplaque CXCL1 levels in FK866-treated mice. In vitro, FK866 did not affect MMP-9 release by neutrophils, but it strongly reduced CXCL1 production by endothelial cells which, in the in vivo model, were identified as a main CXCL1 source at the plaque level. CXCL1 synthesis inhibition by FK866 appears to reflect interference with nuclear factor-κB signalling as shown by reduced p65 nuclear levels in endothelial cells pre-treated with FK866. In conclusion, pharmacological inhibition of NAMPT activity mitigates inflammation in atherosclerotic plaques by reducing CXCL1-mediated activities on neutrophils. These results support further assessments of NAMPT inhibitors for the potential prevention of plaque vulnerability.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1160/th13-07-0531

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 51

Metadata

Authors
da Silva, R. F., Fraga-Silva, R. A., Steffens, S., Fabre, M., Bauer, I., Caffa, I., Magnone, M., Sociali, G., Quercioli, A., Pelli, G., Lenglet, S., Galan, K., Burger, F., Calvo, S. V., Bertolotto, M., Bruzzone, S., Ballestrero, A., Patrone, F., Dallegri, F., Santos, R. A. S., Stergiopulos, N., Mach, F., Vuilleumier, N., Montecucco, F., & Nencioni, A.
Venue
Thrombosis and Haemostasis
Published
2014
Volume
112
Issue
02
Pages
308-322
ISSN
  • 0340-6245 (ISSN-L)
  • 2567-689X
OpenAlex
W2098274411
Cited by
51
References
2
FWCI
3.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. https://app.cochat.ai/papers/10.1160/th13-07-0531
The paper
da Silva, R. F., Fraga-Silva, R. A., Steffens, S., Fabre, M., Bauer, I., Caffa, I., Magnone, M., Sociali, G., Quercioli, A., Pelli, G., Lenglet, S., Galan, K., Burger, F., Calvo, S. V., Bertolotto, M., Bruzzone, S., Ballestrero, A., Patrone, F., Dallegri, F., . . . Nencioni, A. (2014). Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. Thrombosis and Haemostasis. https://doi.org/10.1160/th13-07-0531

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.